Chemed (NYSE:CHE) Issues Quarterly Earnings Results

Chemed (NYSE:CHE) announced its earnings results on Tuesday. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46, FiscalAI reports. The firm had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.27 EPS. Chemed updated its FY 2026 guidance to 25.000-25.750 EPS.

Chemed Stock Up 4.6%

CHE stock traded up $23.77 during trading on Wednesday, hitting $541.40. 26,986 shares of the stock traded hands, compared to its average volume of 221,419. Chemed has a 1 year low of $365.20 and a 1 year high of $551.68. The firm’s 50 day moving average is $461.43 and its two-hundred day moving average is $434.63. The stock has a market cap of $7.18 billion, a price-to-earnings ratio of 29.76, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. Chemed’s payout ratio is presently 13.08%.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Commonwealth Equity Services LLC raised its position in Chemed by 3.1% in the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after buying an additional 22 shares during the last quarter. Cim LLC grew its stake in shares of Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after acquiring an additional 24 shares during the period. Merit Financial Group LLC raised its holdings in shares of Chemed by 4.0% during the third quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock valued at $421,000 after purchasing an additional 36 shares during the last quarter. Deutsche Bank AG raised its holdings in shares of Chemed by 1.2% during the fourth quarter. Deutsche Bank AG now owns 2,929 shares of the company’s stock valued at $1,253,000 after purchasing an additional 36 shares during the last quarter. Finally, Public Employees Retirement System of Ohio lifted its position in Chemed by 0.8% during the third quarter. Public Employees Retirement System of Ohio now owns 5,007 shares of the company’s stock valued at $2,242,000 after purchasing an additional 40 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CHE. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research note on Wednesday. Royal Bank Of Canada raised their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Finally, Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $480.25.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.